USNA (STOCKS)
USANA Health Sciences Inc
$21.140000
-0.290000 (-1.35%)
Prev close: $21.430000
Company Information
- Exchange
- XNYS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Other
- CEO
- Kevin G. Guest
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $388.09M
- Employees
- 1,700
- P/E (TTM)
- 24.08
- P/B (TTM)
- 0.74
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
0
Strong Buy
0
Buy
3
Hold
1
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Sep 2025 (Q3)
|
$-0.15 | $0.48 | -0.6294 | -131.29% |
|
Jun 2025 (Q2)
|
$0.74 | $0.55 | +0.1892 | +34.35% |
|
Mar 2025 (Q1)
|
$0.73 | $0.71 | +0.0160 | +2.24% |
|
Dec 2024 (Q4)
|
$0.64 | $0.50 | +0.1407 | +28.18% |
Financial Statements
| Revenues | $912.67M |
| Benefits Costs and Expenses | $864.89M |
| Cost Of Revenue | $190.00M |
| Costs And Expenses | $864.89M |
| Gross Profit | $722.67M |
| Nonoperating Income/Loss | $5.96M |
| Operating Expenses | $680.85M |
| Selling, General, and Administrative Expenses | $332.64M |
| Other Operating Expenses | $336.64M |
| Operating Income/Loss | $41.82M |
| Income/Loss From Continuing Operations After Tax | $17.56M |
| Income/Loss From Continuing Operations Before Tax | $47.78M |
| Income Tax Expense/Benefit | $30.22M |
| Net Income/Loss | $17.56M |
| Net Income/Loss Attributable To Noncontrolling Interest | $567.00K |
| Net Income/Loss Attributable To Parent | $16.99M |
| Net Income/Loss Attributable To Redeemable Noncontrolling Interest | $567.00K |
| Net Income/Loss Available To Common Stockholders, Basic | $16.99M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | $0.88 |
| Diluted Earnings Per Share | $0.88 |
| Basic Average Shares | 37,069,000 |
| Diluted Average Shares | 37,085,000 |
| Assets | $726.59M |
| Current Assets | $264.07M |
| Inventory | $90.78M |
| Other Current Assets | $173.28M |
| Noncurrent Assets | $462.53M |
| Fixed Assets | $96.21M |
| Intangible Assets | $138.16M |
| Other Non-current Assets | $228.16M |
| Liabilities | $145.04M |
| Current Liabilities | $118.66M |
| Accounts Payable | $16.22M |
| Other Current Liabilities | $102.45M |
| Noncurrent Liabilities | $26.37M |
| Redeemable Noncontrolling Interest | $53.48M |
| Equity | $528.07M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $528.07M |
| Temporary Equity | $53.48M |
| Liabilities And Equity | $726.59M |
| Net Cash Flow From Operating Activities | $31.52M |
| Net Cash Flow From Operating Activities, Continuing | $31.52M |
| Net Cash Flow From Investing Activities | -$216.37M |
| Net Cash Flow From Investing Activities, Continuing | -$216.37M |
| Net Cash Flow From Financing Activities | -$31.13M |
| Net Cash Flow From Financing Activities, Continuing | -$31.13M |
| Net Cash Flow | -$215.98M |
| Net Cash Flow, Continuing | -$215.98M |
| Comprehensive Income/Loss | $11.97M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $567.00K |
| Comprehensive Income/Loss Attributable To Parent | $11.40M |
| Other Comprehensive Income/Loss | -$5.59M |
| Other Comprehensive Income/Loss Attributable To Parent | -$5.59M |